BST2 and cancer: Findings from many labs have shown that BST-2 is overexpressed in several cancers including lung cancer [17], head and neck carcinomas [18], oral cavity cancers [19], glioblastomas [20], endometrial cancer [21], lymphomas [22], and breast cancer [23,24].